Back to results
US 2014/0273211 A1Published application
Methods and Materials for Hematoendothelial Differentiation of Human Pluripotent Stem Cells Under Defined Conditions
AssigneeWisconsin Alumni Research Foundation
InventorsIgor I. Slukvin, Gene Ichiro Uenishi
Life of this patent
Estimating the term…
Abstract
Methods and compositions for differentiating pluripotent stem cells into cells of endothelial and hematopoietic lineages are disclosed.
Claims15
A method of differentiating human pluripotent stem cells, comprising the steps of:
- (a) providing human pluripotent stem cells;
- and
- (b) exposing the stem cells to a mixture comprising components FGF2, BMP4, Activin A, and LiCl under hypoxic conditions for a period of about two days to form a population of EMHlin−KDR+APLNR+PDGFRalpha+ primitive mesoderm cells with mesenchymoangioblast potential.
A xenogen-free culture medium for differentiating human pluripotent stem cells, comprising IF9S medium supplemented with:
- about 10 to about 50 ng/ml FGF2;
- and
- about 20 to about 50 ng/ml VEGF.
A xenogen-free cell culture system for differentiating human pluripotent stem cells into mesoderm, endothelial, and hematopoietic progenitor cells, comprising;
- human pluripotent stem cells seeded as a single cell suspension on a substrate comprising a layer of Tenascin C at a concentration of at least about 0.25 μg/cm2 to about 1 μg/cm2;
- and
- a xenogen-free culture medium comprising IF9S medium supplemented with:
- about 50 to about 250 ng/ml BMP4;
- about 10 to about 15 ng/ml Activin A;
- about 10 to about 50 ng/ml FGF2;
- and
- about 1 to about 2 mM LiCl.
5 more elements
Dependencies are inferred from the claim text.